Bruce Neal's Publications

• Salt-related knowledge, attitudes and behaviors (KABS) among victorian adults following 22-months of a consumer awareness campaign

  Journal articles

  2020

  Nutrients

• Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Sex disparities in cardiovascular outcome trials of populations with diabetes: A Systematic Review and Meta-analysis

  Journal articles

  2020

  Diabetes Care

• A Systematic Review of the Sources of Dietary Salt Around the World

  Journal articles

  2020

  Advances in Nutrition

• Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: Modelling study

  Journal articles

  2020

  The BMJ

• A Novel Cardioprotective Therapy That Also Improves Glycemia

  Journal articles

  2020

  JAMA - Journal of the American Medical Association

• A comparison of the nutritional qualities of supermarkets own and regular brands of bread in sweden

  Journal articles

  2020

  Nutrients

• Changes in sodium levels of processed foods among the International Food and Beverage Association member companies in Australia: 20132017

  Journal articles

  2020

  Journal of Food Composition and Analysis

• Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

  Journal articles

  2020

  Diabetes, Obesity and Metabolism

• CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS

  Conference Abstracts

  2020

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

• EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL

  Conference Abstracts

  2020

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

• EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL

  Conference Abstracts

  2020

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

• EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION

  Conference Posters

  2020

• Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)

  Journal articles

  2020

  American Heart Journal

• Global, regional, and national burden of chronic kidney disease, 19902017: a systematic analysis for the Global Burden of Disease Study 2017

  Journal articles

  2020

  The Lancet

• Effect of dose and duration of reduction in dietary sodium on blood pressure levels: Systematic review and meta-analysis of randomised trials

  Journal articles

  2020

  The BMJ

• A Community-Based Intervention for Managing Hypertension in Rural South Asia.

  Journal articles

  2020

  New England Journal of Medicine

• Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

  Journal articles

  2020

  Journal of the American Heart Association

• Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

  Journal articles

  2020

  Circulation

• Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men

  Journal articles

  2020

  Diabetes, Obesity and Metabolism

• Sources of dietary sodium and implications for a state-wide salt reduction program in Victoria, Australia

  Journal articles

  2020

  British Journal of Nutrition

• Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes

  Journal articles

  2020

  JACC: Heart Failure

• Associations Between TNFR-1, TNFR-2, and KIM-1 with Kidney and Cardiovascular Outcomes: Results from the CANVAS Trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Acute Declines in eGFR During Treatment with Canagliflozin (CANA) and Its Implications for Clinical Practice: Insights from CREDENCE

  Journal articles

  2020

  Journal of the American Society of Nephrology

• The SGLT2 Inhibitor Canagliflozin Reduces the Plasma Markers TNFR-1, TNFR-2, and KIM-1 in the CANVAS Trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Canagliflozin Treatment Reduces Formation and Increases Degradation of Collagen Type III in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

  Journal articles

  2020

  Journal of the American Society of Nephrology